In vivo effects of reversible inhibitors of cholinesterase activity were determined radiometrically in undiluted samples of erythrocytes and plasma. [ 14 C]acetylcholine at substrate saturation, 25 °C and pH 7.4 permitted rapid and precise determination of butyrylcholinesterase (EC 3.1.1.8) and acetylcholinesterase (EC 3.1.1.7) activities. Reference values for acetylcholinesterase and butyrylcholinesterase were estimated in the plasma and erythrocyte haemolysate of 102 healthy volunteers.
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Substrate consumption serves as a measure of enzyme activity. Since reaction velocity remains constant (zero order reaction) only at substrate saturation, the reaction must be stopped before the decreasing substrate concentration leads to a first order reaction. Therefore, the linearity of the enzyme reaction was checked in relation to the incubation period and appropriate time intervals were established for the measurements. In agreement with previous authors (6, 7), a satisfactory correlation was found down to 50% of the initial substrate concentration.
Chemicals, radioactive compounds, drugs All chemicals were commercially available and of the highest available degree of purity. [ 14 C]acetylcholine-iodide is a product of NEN, Boston, U. S. A. Eserine and tacrine were provided by SERVA, Heidelberg, F. R. G., pyridostigmine is a product of ROCHE, Grenzach-Wyhlen, F. R. G.
Preparation of samples
Human plasma and erythrocytes were obtained from healthy male and female volunteers by venepuncture of the elbow. Coagulation was prevented by crystalline heparine; whole blood was centrifuged for 10 minutes at 2200 g and the plasma drawn off with a pipette. Erythrocytes were haemolyzed by freezing three times in liquid nitrogen and thawing. Samples were adjusted to pH 7.4 prior to incubation.
Incubation procedure
In an Eppendorf micro test tube, 10 μΐ of substrate solution were added to 100 μΐ of sample material, blended immediately for 10 seconds with a mixer and subsequently incubated at 25 °C while being shaken in a water bath (Thermomix 1460, Braun-Melsungen, F. R.G.). Substrate concentrations were 10 mmol/I for butyrylcholinesterase and 4 mmol/1 for acetylcholinesterase in erythrocytes. [ 14 C]acetylcholine-iodide was added to yield a specific ratioactivity of 167 kBq/mmol for the butyryl cholinesterase and of 407 kBq/mmol for the acetylcholinesterase. One sample with 100 μΐ buffer without enzyme was used to determine the nonenzymatic hydrolysis. The enzyme activity was stopped by the addition of 1 ml of 2 g/1 glacial acetic acid in ethanol, volume fraction 0.98.
Samples were mixed immediately and centrifuged for 5 minutes at 10000#. From the supernatant, 2 aliquots of 400 μΐ each were taken from erythrocyte samples and 500 μΐ from plasma samples and transferred to counting vials (blank and sample). The initial value for each sample was determined directly from the first aliquot. The second aliquot was diluted with another 500 μΐ of glacial acetic acid and subsequently taken completely to dryness in a Speed Vac Concentrator (Bachofer, Reutlingen, F.R.G.).
After evaporation of free acetic acid, the concentrated aliquots were diluted with distilled water and scintillation fluid, using the same quantities as were added to the directly measured aliquots. They were subsequently shaken twice for 10 seconds to ensure complete mixing of the radioactivity with the scintillator.
Measurement of radioactivity
All samples were carefully dissolved in 1 ml H 2 O as well as 10 ml of a scintillator mixture composed of 100 g naphtalene, 10 g 2.5 diphenyloxazole (PPO), 0.25 g 1.4 bis-(2-4-methyl ; -5-phenoxazolyl) (POPOP) with 11 dioxan and measured in a betacounter (RackBeta Spektral 1219, LKB).
The difference of radioactivity between dried and non-dried aliquots is the index enzyme activity after subtraction of the nonenzyraatic hydrolysis. Enzyme activity (μτηοΐ/min -I) can be calculated from the specific radioactivity (Bq/mmol) of the substrate applied, the incubation time and the amount of plasma and erythrocytes used.
Results

Precision of the method
The precision of the measuring method was tested by multiple determinations. The 20-fold determination of a sample within one day yielded a variation coefficient (CV) of 3.5% in human plasma and 4.5% in human erythrocyte haemolysate.
Plasma and erythrocyte samples from healthy test subjects were used to test the reproducibility on different days. Variation coefficients of 4.7% and 7.5% respectively were determined for a time span of 14 days.
Linearity of the enzyme reaction
The multiple determinations for linearity testing were individually evaluated, and the activity was plotted as difference of radioactivity against incubation time. Enzyme activity correlated well with time until almost 50% of the substrate had been hydrolysed. Results are shown in figures 1 a and 1 b. It can be seen that the incubation intervals used for ordinary testing, 120 seconds for plasma and 15 seconds for erythrocytes, are well in the linear range.
Reference values
Blood samples for the estimation of acetyl-and butyrylcholinesterase activities were obtained from the staff of a university hospital, Klinikum Steglitz, Freie Universit t Berlin, on the occasion of a medical examination routine. 102 male and female volunteers took part, with an age of 16 to 57 years, without obvious illnesses and without intake of drugs, 14 days prior to investigation. The use of oral contraceptives, however, was no exclusion criterion but separately monitored. The median age of the females was 32 (range 16-57 years) and the median age of the males 31 (range 20 -55 years).
The reference samples were evaluated according to Stamm (14) . Butyrylcholinesterase activities of 2.05 ± 0.40 (kU/1) with a range of 1.34-2.77 (kU/1) for males and 1.92 ± 0.40 (kU/1) with a range of 1.15-2.71 (kU/1) for females were estimated. The acetyl- cholinesterase activity was calculated as 6.14 ± 0.95 (kU/1) with a range of 3.93-8.25 (kU/1) for males and 6.00 ±1.18 (kU/1) with a range of 3.80-8.36 (kU/1) for females.
The enzyme activities of acetylcholinesterase and butyrylcholinesterase were bimodally distributed. A first maximum of distribution was seen at 0.80 and at 2.60 (kU/1) for the butyryl-and the acetylcholinesterase, respectively, and these were not the same individuals.
Similar findings have been reported (8) for serum paraoxonase, but not yet for cholinesterases. With a cut-off value of 1.0 (kU/1) for the butyrylcholinesterase and 3.5 (kU/1) for the acetylcholinesterase, the frequency distribution was normal and the data could be well described with a Gaussian curve ( fig. 2a +  b The butyrylcholinesterase activity was lower in females than in males, as already reported by various authors (9) (10) (11) . In the present work, this difference was not statistically significant, and the data are in accordance with the work of Prellwitz et al. ((12) , tab. 1). No statistically significant differences were seen in the acetyl-and butyrylcholinesterase activities between women who were (n = 16) and those who were not (n = 45) using oral contraceptives; this finding has already been published elsewhere for butyrylcholinesterase (11) . In 10 brain areas of 23 men and 22 women post mortem, Kewitz et al. found no significant differences between sexes for the acetylcholinesterase activity (13) .
Stability of the samples
The time course of inhibition by the inhibitors was determined in vitro in order to see whether enzyme activity recovers during the time interval of the experimental procedure. No relevant recovery was found in human plasma within 10 hours at 25 °C with tacrine ( fig. 3 a) or pyridostigmine ( fig. 3 c) , whereas a relevant/significant (concentration dependent) recovery was seen with eserine ( fig. 3 b) . The storage of plasma samples for up to 28 days at -20 °C led to no significant change of enzyme activity, which agrees with the findings of other authors (11, 18) .
Kinetics of inhibition
The kinetics of esterase inhibition were determined in vitro at 25 °C immediately after various inhibitors at different concentrations had been added. The time interval for maximal inhibition was markedly longer at lower concentrations. The time intervals for preincubations in the subsequent concentration-response tests were accordingly adjusted and kept constant in all experiments. Preincubation periods were 60 minutes with eserine or tacrine and 90 minutes for pyridostigmine. Inhibition by tacrine and pyridostigmine remained constant at 25 °C over a period of about 10 hours. An early recovery was seen with eserine, especially at lower concentrations. These findings are shown in figures 3 a-c. 
Effects of dilution
Tacrine was added to human plasma or erythrocytes in a final concentration of 2.5 μιήοΐ/ΐ. These samples were then diluted up to 100-fold. Recovery of enzyme activity was related to concentration, and in the case of acetylcholinesterase, recovery was nearly 100% at 100-fold dilution; at a similar dilution, the recovery of butyrylcholinesterase amounted to only 50%. Results of these tests are shown in figures 5 a and 5 b. 
Discussion
In principle, the activity of cholinesterases can be determined by measuring either decrease of substrate (15 -17) or increase of products. Products are acetic acid (6, 7, (18) (19) (20) (21) (22) and choline (10, 23, 24) or thiocholine (11, (25) (26) (27) (28) , if the respective artificial substrate is used.
With few exceptions (16, 17) , the methods currently in use employ considerable dilution. Dilution of the enzyme, however, is followed by considerable recovery from inhibition caused by reversible inhibitors. Therefore to monitor enzyme inhibition, dilution should be avoided (figs. 5 a and 5b). The method described fullfils that requirement. The method is rapid, sensitive, precise and needs small amounts of samples only.
The measurement of the substrate consumption can be used at various substrate concentrations and also at different pH values and temperatures. Human erythrocytes show an activity of about 6 · ΙΟ 3 μιηοΐ/ min · l (30) which means that 1 ml hydrolyses more than the substrate concentration at saturation in one minute if used undiluted. It can be concluded that enzymatic hydrolysis is zero order in an undiluted sample for a few seconds only. Winteringham & Disney (16) in 1962 introduced the measurement principle of determining the cholinesterase activities in undiluted materials by means of radiometry of unhydrolysed 14 C-labelled acetylcholine. The precision of the method, however, was low and numerous modifications have been proposed to improve the test.
In the procedure described in this paper, the pH value 7.4 was chosen to mimic physiological conditions as closely as possible. Inhibition is pH-dependent; moreover the increase of nonenzymatic hydrolysis occurring at a more alkaline pH is thus largely prevented. The temperature of 25 °C is applicable for 90% of the year and at other times it is slightly above room temperature in our climate. A lower temperature would have been favorable but would have required a more complicated cooling system. A higher temperature, on the other hand, would have reduced the short incubation time for undiluted samples even further. Various authors have stressed the significance of the preincubation time interval of inhibitors of cholinesterases in the absence of substrate for the comparability of in vitro experiments (4, 31).
As La Du & Eckerson (8) described for other enzymes, the acetyl-and butyrylcholinesterase activities of our volunteer panel represented a bimodal distribution. Genetic polymorphism might have contributed to this finding, because our reference panel is not a representative part of the population and has not been screened with regard to heterozygotes or homozygotes for the atypical enzyme. It is known that phenotypes are differentiated at 25 °C, which was the standard of the present examination, more distinctly than at other incubation temperatures (32). Further investigations will be performed to verify the data.
From the present findings it may be concluded that the determination of substrate consumption by radioactivity measurement permits a rapid and easily reproducible determination of the acetyl-and butyrylcholinesterase activities in undiluted samples. The method is suitable for estimating the inhibition of cholinesterases by reversible inhibitors in vivo, and it is appropriate for monitoring treatment. It is known from patients with a 'silent gene', who are devoid of any butyrylcholinesterase activity, that this condition is not a life threatening factor per se (33) . Additionally there is no correlation between plasma cholinesterase and erythrocyte cholinesterase, and persons with atypical plasma cholinesterase have normal erythrocyte acetylcholinesterase activities (34) . Therefore the monitoring of both enzymes, acetyl-and butyrylcholinesterase is needed, particularly within a narrow therapeutic range.
